Literature DB >> 11886899

Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS.

Cynthia M J Higgins1, Cheolwha Jung, Hongliu Ding, Zuoshang Xu.   

Abstract

Mutations in Cu, Zn superoxide dismutase (SOD1) cause a fraction of amyotrophic lateral sclerosis (ALS), which involves motoneuron degeneration, paralysis, and death. An acquired activity by mutant SOD1 is responsible for the cellular toxicity, but how mutant SOD1 kills motoneurons is unclear. In transgenic mouse models of ALS, mitochondrial degeneration occurs early, before disease onset, raising the question of how mutant SOD1 damages mitochondria. Here we investigate the intracellular localization of SOD1 in the CNS to determine whether SOD1 is present in mitochondria, where it could directly damage this organelle. We show that endogenous mouse SOD1, wild-type human, and mutant human SOD1 (G93A), when expressed as transgenes, are colocalized with mitochondria in spinal cord by immunofluorescence confocal microscopy. By immunoelectron microscopy, we show that SOD1 is present within mitochondria at similar concentrations as in the cytoplasm. Thus SOD1, in addition to being a cytosolic enzyme, is present inside mitochondria in the CNS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886899      PMCID: PMC6758252     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  81 in total

Review 1.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

Review 3.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

Review 4.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

5.  Increased expression of a proline-rich Akt substrate (PRAS40) in human copper/zinc-superoxide dismutase transgenic rats protects motor neurons from death after spinal cord injury.

Authors:  Fengshan Yu; Purnima Narasimhan; Atsushi Saito; Jing Liu; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2007-04-25       Impact factor: 6.200

Review 6.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

Review 7.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

8.  Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice.

Authors:  Chetan Vijayvergiya; M Flint Beal; Jochen Buck; Giovanni Manfredi
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

Review 9.  Copper chaperones: personal escorts for metal ions.

Authors:  Lori Sturtz Field; Edward Luk; Valeria Cizewski Culotta
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

10.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.